ENTERA BIO IS-0000769
Entera Bio Ltd., a clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs. The company leverages its N-Tab platform that is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream. It also develops EB613, an oral PTH (1-34), that has completed Phase 2 clinical trial … Read more
Market Cap & Net Worth: ENTERA BIO IS-0000769 (5DT)
ENTERA BIO IS-0000769 (F:5DT) has a market capitalization of $52.91 Million (€51.54 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #22754 globally and #2470 in its home market, demonstrating a 6.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ENTERA BIO IS-0000769's stock price €1.12 by its total outstanding shares 45857242 (45.86 Million).
ENTERA BIO IS-0000769 Market Cap History: 2020 to 2026
ENTERA BIO IS-0000769's market capitalization history from 2020 to 2026. Data shows change from $38.60 Million to $52.91 Million (-4.11% CAGR).
ENTERA BIO IS-0000769 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ENTERA BIO IS-0000769's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 5DT by Market Capitalization
Companies near ENTERA BIO IS-0000769 in the global market cap rankings as of March 19, 2026.
Key companies related to ENTERA BIO IS-0000769 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
ENTERA BIO IS-0000769 Historical Marketcap From 2020 to 2026
Between 2020 and today, ENTERA BIO IS-0000769's market cap moved from $38.60 Million to $ 52.91 Million, with a yearly change of -4.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €52.91 Million | -24.46% |
| 2025 | €70.04 Million | -26.34% |
| 2024 | €95.08 Million | +322.59% |
| 2023 | €22.50 Million | -20.83% |
| 2022 | €28.42 Million | -76.41% |
| 2021 | €120.50 Million | +212.20% |
| 2020 | €38.60 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ENTERA BIO IS-0000769 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $52.91 Million USD |
| MoneyControl | $52.91 Million USD |
| MarketWatch | $52.91 Million USD |
| marketcap.company | $52.91 Million USD |
| Reuters | $52.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.